Investigation of Antimicrobial and Anti-Inflammatory Efficacy of Newly Synthesized Pyrogallol-Coumarin Hybrids: In Vitro and In Silico Studies
The aim of this study is to present the synthesis of two new compounds with promising antimicrobial and anti-inflammatory properties using precursors that contain pyrogallol and coumarin units. The characterization of the obtained compounds ( ) ( )- '-(1-(2,4-dioxochroman-3-ylidene)ethyl)-2,3,4...
Gespeichert in:
Veröffentlicht in: | Pharmaceutics 2024-11, Vol.16 (11), p.1472 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of this study is to present the synthesis of two new compounds with promising antimicrobial and anti-inflammatory properties using precursors that contain pyrogallol and coumarin units.
The characterization of the obtained compounds (
) (
)-
'-(1-(2,4-dioxochroman-3-ylidene)ethyl)-2,3,4-trihydroxybenzohydrazide (
) and (
)-
'-(1-(2,4-dioxochroman-3-ylidene)ethyl)-3,4,5-trihydroxybenzohydrazide (
) was performed using various spectroscopic methods in combination with the DFT methods. To evaluate antimicrobial and anti-inflammatory activities,
were tested against 13 different types of microorganisms and soybean lipoxygenase. To determine the specific mechanisms of anti-LOX activity, molecular docking and molecular dynamics studies were performed.
These compounds had the most potent antibacterial activity against the bacterium
ATCC 12453, with a MIC value of 31.125 µg/mL. In addition, three standard bacterial species were chosen to evaluate the antibiofilm activity of tested substances. The results showed that the strongest effect of
was noticed on the biofilm formation of
ATCC 25923 (BIC
at 378 µg/mL). The anti-LOX results indicate that
have excellent activity with the IC
value for
= 38.12 μM and
= 34.12 μM.
The obtained in vitro and in silico results confirm the strong inhibitory potential of the investigated compounds. |
---|---|
ISSN: | 1999-4923 1999-4923 |
DOI: | 10.3390/pharmaceutics16111472 |